NDC 69097-321-86 - Budesonide Inhalation Suspension
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 69097-321
- Requested NDC
- 69097-321-86
- Package NDCs from labels
- 69097-321-86, 69097-321-87, 69097-321-32, 69097-321-53
- Manufacturer
- Cipla USA Inc. | CIPLA LIMITED GOA | CIPLA LIMITED INDORE | Cipla (Jiangsu) Pharmaceutical Co., Ltd.
- Effective date
- 2026-06-10
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Budesonide Inhalation Suspension | Cipla USA Inc. | CIPLA LIMITED GOA | CIPLA LIMITED INDORE | Cipla (Jiangsu) Pharmaceutical Co., Ltd. | 2026-06-10 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 69097-321-32 | BudesonideInhalation Suspension | 2 mL in 1 AMPULE | INHALANT | 2 | 12 | |
| 69097-321-32 | BudesonideInhalation Suspension | 1 in 1 POUCH | INHALANT | 1 | 12 | |
| 69097-321-53 | BudesonideInhalation Suspension | 30 in 1 CARTON | INHALANT | 30 | 12 | |
| 69097-321-86 | BudesonideInhalation Suspension | 2 mL in 1 AMPULE | INHALANT | 2 | 12 | |
| 69097-321-86 | BudesonideInhalation Suspension | 5 in 1 POUCH | INHALANT | 5 | 12 | |
| 69097-321-87 | BudesonideInhalation Suspension | 6 in 1 CARTON | INHALANT | 6 | 12 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 69097-321-32 | ML - Milliliter | 69097-321 | eb019ceb-9ce2-46b0-9a47-6b113aa8da20 | 1 | 2020-09-14 |
| 69097-321-53 | ML - Milliliter | 69097-321 | 1b6883a7-5982-4fc4-a3cd-a0fd2ce24e02 | 1 | 2020-08-06 |
| 69097-321-86 | ML - Milliliter | 69097-321 | f30aa7f6-bcf5-4a34-9751-2b2ef1f87e73 | 1 | 2018-03-08 |
| 69097-321-87 | ML - Milliliter | 69097-321 | 89a7705b-8a3c-4692-84a2-a467bc955649 | 1 | 2017-12-14 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Additive Formula 3 | DEXTROSE MONOHYDRATE, TRISODIUM CITRATE DIHYDRATE, SODIUM CHLORIDE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, CITRIC ACID MONOHYDRATE, AND ADENINE | Terumo BCT, Ltd | 9a5247a1-cc05-442d-b2d0-950f887f03c2 | 2026-01-30 | Warnings, Adverse reactions | 2968PHW8QP 451W47IQ8X |
| CVS ULTRA FINE MOISTURIZING SALINE MIST | NASAL MIST | CVS | 44821c47-63f9-5d0a-e063-6394a90a555d | 2026-01-29 | Warnings | 451W47IQ8X |
| PULMICORT FLEXHALER | BUDESONIDE | A-S Medication Solutions | 5d0c6c7e-2f53-4238-ab34-bd8cf49d8a66 | 2026-01-29 | Warnings, Adverse reactions | Q3OKS62Q6X |
| Sodium Citrate and Citric Acid | SODIUM CITRATE AND CITRIC ACID MONOHYDRATE | Atlantic Biologicals Corp. | 42d837ae-2578-46df-92d2-24774964aaad | 2026-01-28 | Adverse reactions | 1Q73Q2JULR |
| Sodium Chloride | SODIUM CHLORIDE | Nephron Pharmaceuticals Corporation | a4edf2d5-a9ff-30d4-e053-2995a90a5650 | 2026-01-26 | Warnings, Adverse reactions | 451W47IQ8X |
| Tarpeyo | BUDESONIDE | Calliditas Therapeutics AB | 938cada4-d6bf-4252-836f-dd40f9eadb4d | 2026-01-21 | Warnings, Adverse reactions | Q3OKS62Q6X |
| Budesonide | BUDESONIDE | Walgreens | 9d519bf3-8d9b-5208-13c5-308edc24aca7 | 2026-01-21 | Warnings | Q3OKS62Q6X |
| Budesonide | BUDESONIDE | CVS Pharmacy | b2650d29-c011-48f1-a7f4-040011d4563d | 2026-01-21 | Warnings | Q3OKS62Q6X |
| Sodium Chloride | SODIUM CHLORIDE | ProPharma Distribution | 48d73434-e65b-dc98-e063-6294a90affa2 | 2026-01-20 | Adverse reactions | 451W47IQ8X |
| Equate Comfort Flow Sinus wash | SINUS WASH | WALMART INC | 9e911eef-ca99-9902-e053-2a95a90aab0e | 2026-01-19 | Warnings | 451W47IQ8X |
| EQUATE PREMIUM SALINE | SODIUM CHLORIDE 0.65% | Walmart Stores, Inc. | 1e17f022-f513-140d-e063-6394a90a379e | 2026-01-19 | Warnings | 451W47IQ8X |
| Sodium chloride | SODIUM CHLORIDE | Fresenius Kabi USA, LLC | d98bf9f7-30ec-4927-a577-cabad192cb18 | 2026-01-19 | Warnings, Adverse reactions | 451W47IQ8X |
| SWISS BLEU Relief-Calm Antimicrobial Skin Cream | LACTOBACILLUS FERMENT LYSATE, LEONTOPODIUM ALPINUM, CALENDULA OFFICINALIS FLOWER EXTRACT, EVENING PRIMROSE FLOWER EXTRACT, CITRIC ACID | Nanjing Hongruixing Biological Technology Co., Ltd | 487d3c2c-ce28-f7a1-e063-6294a90a5ec6 | 2026-01-16 | Warnings | 2968PHW8QP |
| Sodium Chloride Hypertonicity | SODIUM CHLORIDE | CVS Pharmacy | 9245d842-7f78-42d8-83ba-8eb9ec8dbc0d | 2026-01-15 | Warnings | 451W47IQ8X |
| Sodium Chloride Hypertonicity | SODIUM CHLORIDE | CVS PHARMACY | d5cc6cd1-ddf8-4f5b-a021-204cdda0db94 | 2026-01-15 | Warnings | 451W47IQ8X |
| Constipation Relief | ALUMINUM OXIDE, BRYONIA ALBA ROOT, SODIUM CHLORIDE, GRAPHITE, SILICON DIOXIDE | Homeocare Laboratories | 62374240-cd14-44e2-9405-5f8996faf047 | 2026-01-12 | Warnings | 451W47IQ8X |
| Luffa | LUFFA, HYDRASTIS CANADENSIS, MERCURIUS SULPH. RUB, ALLIUM CEPA, NATRUM MURITICUM, PHOSPHORUS, EUPATORIUM PERF, STICTA | Marco Pharma International LLC. | 7dbb79de-c3f5-4245-884a-a6bd29bb861c | 2026-01-12 | Warnings | 451W47IQ8X |
| Hepaticol Drops 5008 | HEPATICOL DROPS | Professional Complementary Health Formulas | 79ee9e37-7853-4560-a87d-cdaefb603bbb | 2026-01-08 | Warnings | 451W47IQ8X |
| Weight Management Formula 7534 | WEIGHT MANAGEMENT FORMULA | Professional Complementary Health Formulas | f0406b63-7b97-4b2c-b976-75e8890818c6 | 2026-01-08 | Warnings | 451W47IQ8X |
| Acne Drops 2001 | ACNE DROPS | Professional Complementary Health Formulas | 340fc7dc-2aa4-411f-842b-4ce704671722 | 2026-01-08 | Warnings | 451W47IQ8X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.